Home > > Middle East & Africa And Global Osteoarthritis Therapeutics Market- Size, Share, Growth Rate, and Forecast
TABLE OF CONTENTS CHAPTER 1: RESEARCH METHODOLOGY 1.1. Delivery Model 1.2. Hypothesis Creation 1.3. Revenue narrow down of Companies and in-depth interviews 1.4. Data Triangulation and Validation 1.5. About Us 1.6. Key market segments CHAPTER 2: PREMIUM INSIGHTS CHAPTER 3: MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET 3.1. OVERVIEW 3.2. MIDDLE EAST & AFRICA 3.2.1. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.2. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.3. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY COUNTRY 3.2.4.1. LATIN AMERICA 3.2.4.1.1. LATIN AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.1.2. LATIN AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.1.3. LATIN AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4.2. MEA 3.2.4.2.1. MEA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.2.2. MEA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.2.3. MEA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION CHAPTER 4: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 4.1. OVERVIEW 4.2. KNEE OSTEOARTHRITIS 4.2.1. KNEE OSTEOARTHRITIS MARKET, BY REGION 4.2.1.1. NORTH AMERICA KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 4.2.1.2. EUROPE KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 4.2.1.3. ASIA KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 4.2.1.4. MIDDLE EAST & AFRICA KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 4.3. HIP OSTEOARTHRITIS 4.3.1. HIP OSTEOARTHRITIS MARKET, BY REGION 4.3.1.1. NORTH AMERICA HIP OSTEOARTHRITIS MARKET, BY COUNTRY 4.3.1.2. EUROPE HIP OSTEOARTHRITIS MARKET, BY COUNTRY 4.3.1.3. ASIA HIP OSTEOARTHRITIS MARKET, BY COUNTRY 4.3.1.4. MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS MARKET, BY COUNTRY 4.4. HAND OSTEOARTHRITIS 4.4.1. HAND OSTEOARTHRITIS MARKET, BY REGION 4.4.1.1. NORTH AMERICA HAND OSTEOARTHRITIS MARKET, BY COUNTRY 4.4.1.2. EUROPE HAND OSTEOARTHRITIS MARKET, BY COUNTRY 4.4.1.3. ASIA HAND OSTEOARTHRITIS MARKET, BY COUNTRY 4.4.1.4. MIDDLE EAST & AFRICA HAND OSTEOARTHRITIS MARKET, BY COUNTRY 4.5. SMALL JOINT OSTEOARTHRITIS 4.5.1. SMALL JOINT OSTEOARTHRITIS MARKET, BY REGION 4.5.1.1. NORTH AMERICA SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY 4.5.1.2. EUROPE SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY 4.5.1.3. ASIA SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY 4.5.1.4. MIDDLE EAST & AFRICA SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY CHAPTER 5: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 5.1. OVERVIEW 5.2. VISCOSUPPLEMENTATION AGENTS 5.2.1. VISCOSUPPLEMENTATION AGENTS MARKET, BY REGION 5.2.1.1. NORTH AMERICA VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 5.2.1.2. EUROPE VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 5.2.1.3. ASIA VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 5.2.1.4. MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 5.3. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS 5.3.1. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY REGION 5.3.1.1. NORTH AMERICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 5.3.1.2. EUROPE NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 5.3.1.3. ASIA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 5.3.1.4. MIDDLE EAST & AFRICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 5.4. ANALGESICS 5.4.1. ANALGESICS MARKET, BY REGION 5.4.1.1. NORTH AMERICA ANALGESICS MARKET, BY COUNTRY 5.4.1.2. EUROPE ANALGESICS MARKET, BY COUNTRY 5.4.1.3. ASIA ANALGESICS MARKET, BY COUNTRY 5.4.1.4. MIDDLE EAST & AFRICA ANALGESICS MARKET, BY COUNTRY 5.5. CORTICOSTEROIDS 5.5.1. CORTICOSTEROIDS MARKET, BY REGION 5.5.1.1. NORTH AMERICA CORTICOSTEROIDS MARKET, BY COUNTRY 5.5.1.2. EUROPE CORTICOSTEROIDS MARKET, BY COUNTRY 5.5.1.3. ASIA CORTICOSTEROIDS MARKET, BY COUNTRY 5.5.1.4. MIDDLE EAST & AFRICA CORTICOSTEROIDS MARKET, BY COUNTRY CHAPTER 6: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.1. OVERVIEW 6.2. PARENTERAL ROUTE 6.2.1. PARENTERAL ROUTE MARKET, BY REGION 6.2.1.1. NORTH AMERICA PARENTERAL ROUTE MARKET, BY COUNTRY 6.2.1.2. EUROPE PARENTERAL ROUTE MARKET, BY COUNTRY 6.2.1.3. ASIA PARENTERAL ROUTE MARKET, BY COUNTRY 6.2.1.4. MIDDLE EAST & AFRICA PARENTERAL ROUTE MARKET, BY COUNTRY 6.3. ORAL ROUTE 6.3.1. ORAL ROUTE MARKET, BY REGION 6.3.1.1. NORTH AMERICA ORAL ROUTE MARKET, BY COUNTRY 6.3.1.2. EUROPE ORAL ROUTE MARKET, BY COUNTRY 6.3.1.3. ASIA ORAL ROUTE MARKET, BY COUNTRY 6.3.1.4. MIDDLE EAST & AFRICA ORAL ROUTE MARKET, BY COUNTRY 6.4. TOPICAL ROUTE 6.4.1. TOPICAL ROUTE MARKET, BY REGION 6.4.1.1. NORTH AMERICA TOPICAL ROUTE MARKET, BY COUNTRY 6.4.1.2. EUROPE TOPICAL ROUTE MARKET, BY COUNTRY 6.4.1.3. ASIA TOPICAL ROUTE MARKET, BY COUNTRY 6.4.1.4. MIDDLE EAST & AFRICA TOPICAL ROUTE MARKET, BY COUNTRY TABLE 73. MIDDLE EAST & AFRICA TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)LIST OF TABLES TABLE 01. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 02. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 03. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 04. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 05. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 06. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($MILLION) TABLE 07. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($MILLION) TABLE 08. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($MILLION) TABLE 09. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 10. LATIN AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 11. LATIN AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 12. LATIN AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 13. MEA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 14. MEA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 15. MEA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 16. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 17. KNEE OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 18. NORTH AMERICA KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 19. EUROPE KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 20. ASIA KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 21. MIDDLE EAST & AFRICA KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 22. HIP OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 23. NORTH AMERICA HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 24. EUROPE HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 25. ASIA HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 26. MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 27. HAND OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 28. NORTH AMERICA HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 29. EUROPE HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 30. ASIA HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 31. MIDDLE EAST & AFRICA HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 32. SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 33. NORTH AMERICA SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 34. EUROPE SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 35. ASIA SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 36. MIDDLE EAST & AFRICA SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 37. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 38. VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 39. NORTH AMERICA VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 40. EUROPE VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 41. ASIA VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 42. MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 43. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 44. NORTH AMERICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 45. EUROPE NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 46. ASIA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 47. MIDDLE EAST & AFRICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 48. ANALGESICS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 49. NORTH AMERICA ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 50. EUROPE ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 51. ASIA ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 52. MIDDLE EAST & AFRICA ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 53. CORTICOSTEROIDS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 54. NORTH AMERICA CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 55. EUROPE CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 56. ASIA CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 57. MIDDLE EAST & AFRICA CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 58. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 59. PARENTERAL ROUTE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 60. NORTH AMERICA PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 61. EUROPE PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 62. ASIA PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 63. MIDDLE EAST & AFRICA PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 64. ORAL ROUTE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 65. NORTH AMERICA ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 66. EUROPE ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 67. ASIA ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 68. MIDDLE EAST & AFRICA ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 69. TOPICAL ROUTE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 70. NORTH AMERICA TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 71. EUROPE TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 72. ASIA TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 73. MIDDLE EAST & AFRICA TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)LIST OF FIGURES CHAPTER 1: RESEARCH METHODOLOGY 1.1. Delivery Model 1.2. Hypothesis Creation 1.3. Revenue narrow down of Companies and in-depth interviews 1.4. Data Triangulation and Validation 1.5. About Us 1.6. Key market segments CHAPTER 2: PREMIUM INSIGHTS CHAPTER 3: MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET 3.1. OVERVIEW 3.2. MIDDLE EAST & AFRICA 3.2.1. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.2. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.3. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY COUNTRY 3.2.4.1. LATIN AMERICA 3.2.4.1.1. LATIN AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.1.2. LATIN AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.1.3. LATIN AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4.2. MEA 3.2.4.2.1. MEA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.2.2. MEA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.2.3. MEA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION CHAPTER 4: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 4.1. OVERVIEW 4.2. KNEE OSTEOARTHRITIS 4.2.1. KNEE OSTEOARTHRITIS MARKET, BY REGION 4.2.1.1. NORTH AMERICA KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 4.2.1.2. EUROPE KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 4.2.1.3. ASIA KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 4.2.1.4. MIDDLE EAST & AFRICA KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 4.3. HIP OSTEOARTHRITIS 4.3.1. HIP OSTEOARTHRITIS MARKET, BY REGION 4.3.1.1. NORTH AMERICA HIP OSTEOARTHRITIS MARKET, BY COUNTRY 4.3.1.2. EUROPE HIP OSTEOARTHRITIS MARKET, BY COUNTRY 4.3.1.3. ASIA HIP OSTEOARTHRITIS MARKET, BY COUNTRY 4.3.1.4. MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS MARKET, BY COUNTRY 4.4. HAND OSTEOARTHRITIS 4.4.1. HAND OSTEOARTHRITIS MARKET, BY REGION 4.4.1.1. NORTH AMERICA HAND OSTEOARTHRITIS MARKET, BY COUNTRY 4.4.1.2. EUROPE HAND OSTEOARTHRITIS MARKET, BY COUNTRY 4.4.1.3. ASIA HAND OSTEOARTHRITIS MARKET, BY COUNTRY 4.4.1.4. MIDDLE EAST & AFRICA HAND OSTEOARTHRITIS MARKET, BY COUNTRY 4.5. SMALL JOINT OSTEOARTHRITIS 4.5.1. SMALL JOINT OSTEOARTHRITIS MARKET, BY REGION 4.5.1.1. NORTH AMERICA SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY 4.5.1.2. EUROPE SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY 4.5.1.3. ASIA SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY 4.5.1.4. MIDDLE EAST & AFRICA SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY CHAPTER 5: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 5.1. OVERVIEW 5.2. VISCOSUPPLEMENTATION AGENTS 5.2.1. VISCOSUPPLEMENTATION AGENTS MARKET, BY REGION 5.2.1.1. NORTH AMERICA VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 5.2.1.2. EUROPE VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 5.2.1.3. ASIA VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 5.2.1.4. MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 5.3. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS 5.3.1. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY REGION 5.3.1.1. NORTH AMERICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 5.3.1.2. EUROPE NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 5.3.1.3. ASIA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 5.3.1.4. MIDDLE EAST & AFRICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 5.4. ANALGESICS 5.4.1. ANALGESICS MARKET, BY REGION 5.4.1.1. NORTH AMERICA ANALGESICS MARKET, BY COUNTRY 5.4.1.2. EUROPE ANALGESICS MARKET, BY COUNTRY 5.4.1.3. ASIA ANALGESICS MARKET, BY COUNTRY 5.4.1.4. MIDDLE EAST & AFRICA ANALGESICS MARKET, BY COUNTRY 5.5. CORTICOSTEROIDS 5.5.1. CORTICOSTEROIDS MARKET, BY REGION 5.5.1.1. NORTH AMERICA CORTICOSTEROIDS MARKET, BY COUNTRY 5.5.1.2. EUROPE CORTICOSTEROIDS MARKET, BY COUNTRY 5.5.1.3. ASIA CORTICOSTEROIDS MARKET, BY COUNTRY 5.5.1.4. MIDDLE EAST & AFRICA CORTICOSTEROIDS MARKET, BY COUNTRY CHAPTER 6: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.1. OVERVIEW 6.2. PARENTERAL ROUTE 6.2.1. PARENTERAL ROUTE MARKET, BY REGION 6.2.1.1. NORTH AMERICA PARENTERAL ROUTE MARKET, BY COUNTRY 6.2.1.2. EUROPE PARENTERAL ROUTE MARKET, BY COUNTRY 6.2.1.3. ASIA PARENTERAL ROUTE MARKET, BY COUNTRY 6.2.1.4. MIDDLE EAST & AFRICA PARENTERAL ROUTE MARKET, BY COUNTRY 6.3. ORAL ROUTE 6.3.1. ORAL ROUTE MARKET, BY REGION 6.3.1.1. NORTH AMERICA ORAL ROUTE MARKET, BY COUNTRY 6.3.1.2. EUROPE ORAL ROUTE MARKET, BY COUNTRY 6.3.1.3. ASIA ORAL ROUTE MARKET, BY COUNTRY 6.3.1.4. MIDDLE EAST & AFRICA ORAL ROUTE MARKET, BY COUNTRY 6.4. TOPICAL ROUTE 6.4.1. TOPICAL ROUTE MARKET, BY REGION 6.4.1.1. NORTH AMERICA TOPICAL ROUTE MARKET, BY COUNTRY 6.4.1.2. EUROPE TOPICAL ROUTE MARKET, BY COUNTRY 6.4.1.3. ASIA TOPICAL ROUTE MARKET, BY COUNTRY 6.4.1.4. MIDDLE EAST & AFRICA TOPICAL ROUTE MARKET, BY COUNTRY TABLE 01. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 02. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 03. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 04. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 05. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 06. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($MILLION) TABLE 07. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($MILLION) TABLE 08. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($MILLION) TABLE 09. MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 10. LATIN AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 11. LATIN AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 12. LATIN AMERICA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 13. MEA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 14. MEA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 15. MEA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 16. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 17. KNEE OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 18. NORTH AMERICA KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 19. EUROPE KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 20. ASIA KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 21. MIDDLE EAST & AFRICA KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 22. HIP OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 23. NORTH AMERICA HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 24. EUROPE HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 25. ASIA HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 26. MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 27. HAND OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 28. NORTH AMERICA HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 29. EUROPE HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 30. ASIA HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 31. MIDDLE EAST & AFRICA HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 32. SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 33. NORTH AMERICA SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 34. EUROPE SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 35. ASIA SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 36. MIDDLE EAST & AFRICA SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 37. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 38. VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 39. NORTH AMERICA VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 40. EUROPE VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 41. ASIA VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 42. MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 43. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 44. NORTH AMERICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 45. EUROPE NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 46. ASIA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 47. MIDDLE EAST & AFRICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 48. ANALGESICS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 49. NORTH AMERICA ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 50. EUROPE ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 51. ASIA ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 52. MIDDLE EAST & AFRICA ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 53. CORTICOSTEROIDS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 54. NORTH AMERICA CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 55. EUROPE CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 56. ASIA CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 57. MIDDLE EAST & AFRICA CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 58. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 59. PARENTERAL ROUTE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 60. NORTH AMERICA PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 61. EUROPE PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 62. ASIA PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 63. MIDDLE EAST & AFRICA PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 64. ORAL ROUTE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 65. NORTH AMERICA ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 66. EUROPE ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 67. ASIA ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 68. MIDDLE EAST & AFRICA ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 69. TOPICAL ROUTE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 70. NORTH AMERICA TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 71. EUROPE TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 72. ASIA TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 73. MIDDLE EAST & AFRICA TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)